4 mg CLS-TA Suprachoriodal Injection

DRUG2 trials

Sponsors

Clearside Biomedical, Inc.

Conditions

PanuveitisUveitisUveitis, AnteriorUveitis, IntermediateUveitis, Posterior

Phase 3

Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis

CompletedNCT03097315

Clearside Biomedical, Inc.Panuveitis, Uveitis, Uveitis, Anterior +2

Start: 2017-04-04End: 2018-01-24Updated: 2021-06-23

Unknown Phase

MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301

CompletedNCT02952001

Clearside Biomedical, Inc.Panuveitis, Uveitis, Uveitis, Anterior +2

Start: 2017-12-13End: 2018-05-22Updated: 2021-06-02

Related Papers

Suprachoroidal triamcinolone acetonide injectable suspension for macular edema associated with noninfectious uveitis: an in-depth look at efficacy and safety

The American Journal of Managed Care2023-02-015 citations

Triamcinolone Acetonide Suprachoroidal Injectable Suspension for Uveitic Macular Edema: Integrated Analysis of Two Phase 3 Studies

Ophthalmology and Therapy2022-11-188 citations

Microinjection via the suprachoroidal space: a review of a novel mode of administration.

2022-11-0118 citations